
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded oral liquid containing aluminum hydroxide, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing aluminum hydroxide is listed. Products containing it are filed in the directory as over-the-counter monograph drugs, in liquid, suspension, tablet, ointment and granule forms.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Aluminum hydroxide is an antacid taken by mouth, also used as a skin protectant, that a pharmacy may compound when prescribed.
Aluminum hydroxide is an antacid. It neutralizes stomach acid and inhibits pepsin, a digestive enzyme, and it binds phosphate in the gut so less is absorbed. It is a listed active ingredient in FDA's OTC Monograph M001 for antacid products, and nonprescription products are marketed under that monograph rather than through individual drug approvals. Examples include aluminum hydroxide oral liquid, labeled to relieve heartburn, acid indigestion and sour stomach, and Gaviscon liquid (aluminum hydroxide and magnesium carbonate). Aluminum hydroxide gel also appears as a skin protectant under OTC Monograph M016, labeled to dry the oozing and weeping of poison ivy, oak and sumac. A prescriber might order aluminum hydroxide compounded in a form or combination that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Aluminum hydroxide antacids carry no boxed warning. Their Drug Facts labels say to ask a doctor or pharmacist before use if you take a prescription drug, because antacids may interact with certain prescription drugs. Combination products add: ask a doctor first if you have kidney disease or are on a magnesium-restricted or sodium-restricted diet. Constipation can occur. Stop and ask a doctor if symptoms last more than 2 weeks. StatPearls notes aluminum can build up and cause toxicity in people with kidney failure and in infants, and that antacids can change how well some medicines, such as digoxin, isoniazid and certain antibiotics, are absorbed. MedlinePlus advises spacing other medicines at least 2 hours from an antacid when your prescriber tells you to take both. StatPearls describes aluminum-containing antacids as acceptable in pregnancy, and LactMed considers antacids acceptable during breastfeeding. Talk to your prescriber or pharmacist about side effects.
Aluminum hydroxide neutralizes gastric acid and inhibits pepsin activity; it is a component of sucralfate. It complexes phosphate in the gastrointestinal tract, reducing phosphate absorption, which StatPearls notes makes it useful in hyperphosphatemia. Oral absorption of aluminum is poor, per LactMed. OTC Monograph M001 lists aluminum hydroxide (including codried gels) as an antacid active ingredient for heartburn, sour stomach and acid indigestion; its professional labeling states that prolonged use of aluminum-containing antacids in renal failure may cause or worsen dialysis osteomalacia, and that prolonged use in normophosphatemic patients may cause hypophosphatemia if phosphate intake is not adequate. StatPearls lists aluminum toxicity in renal failure and in infants (osteopenia, osteomalacia, microcytic anemia, neurotoxicity), plus constipation, fecal impaction, hypomagnesemia and hypophosphatemia, and advises caution in renal failure, heart failure, cirrhosis, edema, low-sodium diets and GI hemorrhage. Antacids can impair absorption of acidic drugs such as digoxin and isoniazid and increase absorption of others such as levodopa and pseudoephedrine; magnesium-containing antacids bind tetracyclines and fluoroquinolones. Monitor phosphate and, in renal impairment, aluminum exposure. Dosing is per prescriber.
Shake the bottle if your label says to. Measure each dose with the oral syringe or dosing cup the pharmacy gave you, never a kitchen spoon. Give the liquid slowly into the mouth. Rinse the syringe with water after each use. Call the pharmacy if you are unsure how to measure.
Storage depends on the vehicle. Water-based liquids with a preservative usually carry a USP <795> beyond-use date of up to 35 days; without a preservative they are kept refrigerated for up to 14 days. Oil-based (nonaqueous) oral liquids may carry up to 90 days. Your label states whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally